Target intelligence / Profile preview

UBOX5 antisense RNA 1 (non-protein coding) (UBOX5-AS1)

Target
UBOX5-AS1
Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA, Other
01

Overview

UBOX5 antisense RNA 1 (non-protein coding), abbreviated as UBOX5-AS1, is a long noncoding RNA (lncRNA) transcribed from the antisense strand of the UBOX5 gene locus located at chromosome 20p13[1]. It does not encode a protein but plays functional regulatory roles at the RNA level. UBOX5-AS1 is significantly upregulated in ovarian endometriosis, particularly under hypoxic conditions where its expression is strongly induced by hypoxia-inducible factor-1α (HIF-1α) signaling. Elevated UBOX5-AS1 promotes epithelial-mesenchymal transition (EMT), cell migration, and invasion in endometrial epithelial cells, processes that are fundamental to the pathogenesis and invasiveness of endometriosis. Knockdown of UBOX5-AS1 reverses these hypoxia-induced changes, confirming its functional importance. It has also been reported to modulate cell proliferation and autophagy through the ALKBH5-regulated pathway, further implicating it in cellular responses associated with disease progression. Its expression profile makes it a promising candidate biomarker and potential therapeutic target in ovarian endometriosis and possibly other gynecological diseases[1][5][6].

Other names
UBOX5-AS1UBOX5 antisense RNA 1UBOX5 antisense RNA 1 (non-protein coding)
02

Mechanism of action

Modulates EMT via HIF-1α-dependent transcriptional activation under hypoxic conditions. Mediates autophagy and proliferation through ALKBH5 pathway.

03

Biological functions

Regulation of epithelial-mesenchymal transition (EMT)Regulation of endometrial epithelial cell migration and invasionModulation of gene expression in hypoxiaRegulation of cell proliferation and autophagy (inferred from ALKBH5 pathway action)
04

Disease associations

EndometriosisPotential biomarker for ovarian endometriosisPossibly other gynecological disorders (dysregulated in multiple gynecological diseases)
05

Biomarkers

UBOX5-AS1 expression (potential noninvasive biomarker for ovarian endometriosis)

Beyond the preview

Go deeper on UBOX5 antisense RNA 1 (non-protein coding) (UBOX5-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBOX5 antisense RNA 1 (non-protein coding) (UBOX5-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call